Global Opioid-induced Constipation (OIC) Treatment Market Driven by Rising Number of Illicit Drug Users

opioid3

The global opioid-induced constipation (OIC) treatment market is a highly attractive market. The market is promising due to the rising base of OIC sufferers. Another impactful driver for the global opioid-induced constipation (OIC) treatment market is the growing number of drug addicts and abusers.

Growing Base of Cancer Patients to Drive Global Opioid-induced Constipation (OIC) Treatment Market
Opioids refer to a class of drugs used for pain relief. They are derived from opium, produced by the poppy plant. Opioids are also known as narcotics or opiates. Using opioids tends to create a sense of euphoria and wellbeing. Hence, opioids can be addictive. Opioids can help reduce the secretion of digestive juices and thus decrease the urge to defecate. Hence, opioid-based therapies are prescribed by doctors to cancer patients to decrease their pain and enhance their quality of life. According to the WHO, the number of new cancer cases is projected to grow by around 70% in the next 20 years. With the growing base of cancer patients, the demand for opioid-induced constipation (OIC) treatment will also grow.

Request For Sample Report:- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6862

Besides this factor, there are several other factors that will drive the global opioid-induced constipation (OIC) treatment. The rising number of illicit drug users using OIC treatment will drive the global opioid-induced constipation (OIC) treatment. In addition to this, the rising number of patients using opioids for a prolonged period to treat chronic pain will also boost the market. Growing awareness among physicians and patients about non-laxative prescriptions to treat cancer patients will further drive the global opioid-induced constipation (OIC) treatment market.

North America to Lead Global Opioid-induced Constipation (OIC) Treatment Market
On the basis of geography, the global opioid-induced constipation (OIC) treatment market is divided into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. Presently, North America dominates the global opioid-induced constipation (OIC) treatment market.

The rising base of OIC sufferers and illicit drug users in North America is driving this regional market. The National Institute on Drug Abuse states that globally, 26.4 mn to 36 mn people tend to abuse opioids. In 2013, the number of opiate prescriptions increased by 207 mn as compared to 76 mn in 1991. At present, the U.S. is the largest end user of opiates globally.

Key Developments in Global Opioid-induced Constipation (OIC) Treatment Market
Introduction of oral, highly targeted peripherally acting mu-opioid receptor antagonist (PAMORA) therapies such as Relistor, Naloxegol, and Bevenopran will boost the overall opioid-induced constipation (OIC) treatment market. Additionally, the rising approval for novel drugs for treating opioid-induced constipation will also fuel the global opioid-induced constipation (OIC) treatment market.

Although the global opioid-induced constipation (OIC) treatment market is projected to witness high growth in the foreseeable future, it will be suppressed by the high prices of novel medicines. Moreover, the high preference for standard laxative therapy and unfavorable reimbursement policies by insurance companies and local authorities will challenge the global opioid-induced constipation (OIC) treatment market.

Some of the top companies operating in the global opioid-induced constipation (OIC) treatment market are Takeda Pharmaceutical Company Limited, S.L.A Pharma AG, Salix Pharmaceuticals, Pfizer, Inc., Cubist Pharmaceuticals, Inc., AstraZeneca plc, and AIKO Biotechnology, Inc.

Browse Full Global Opioid-induced Constipation (OIC) Treatment Market Report With Complete TOC @ http://www.transparencymarketresearch.com/opioidinduced-constipation-treatment-market.html

About Us:-
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:-
Mr.Nachiket
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +15186181030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s